First to cure type 1 diabetes without insulin or immunosuppression
The finish line
A broadly applicable therapy produces normal glucose regulation for five years without exogenous insulin or systemic immunosuppression.
Why it is still open
NIH says current islet transplants require lifelong immunosuppression and remain suitable for only a small subset.
NIH/NIDDK · Islet transplantation ↗